HHS to Fund Commercial Manufacturing Tests for BioProtection Systems’ Ebola Vaccine
The U.S. Department of Health and Human Services has awarded BioProtection Systems a contract with $24.75 million in base funds to support commercial manufacturing tests of the company’s anti-Ebola vaccine. HHS said Tuesday said the tests will work to validate whether manufacturing processes created under a previous contract would produce enough V920 vaccines in the event of an Ebola outbreaks. Funds from the HHS Office […] More